Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. (Q51888776)
Jump to navigation
Jump to search
scientific article published on 8 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. |
scientific article published on 8 April 2008 |
Statements
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. (English)
Guido Reifenberger
1 reference
Jörg Felsberg
1 reference
Robert Charles Janzer
Marie-France Hamou
Annie-Claire Diserens
Roger Stupp
Thierry Gorlia
Christine Marosi
Harald Heinzl
Johannes A Hainfellner
8 April 2008
520-532
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference